Buying or selling a cannabis business in New York

Legal status and regulator

New York legalized adult-use cannabis in March 2021 under the Marihuana Regulation and Taxation Act. The Cannabis Control Board approves licenses and ownership changes. The Office of Cannabis Management (OCM) is its staff agency and also runs the medical and cannabinoid hemp programs.

License types and how many exist

New York does not publish a hard statewide cap, but it paces application windows, so new retail licenses are not available on demand. Per OCM’s 2025 annual report, 2,413 adult-use licenses had been issued by 30 November 2025 and 2,008 were active:

License type	Active, 30 Nov 2025
Retail dispensary	770 (519 stores open)
Processor	465
Microbusiness	309
Cultivator	249
Distributor	215

The gap between 770 retail licenses and 519 open stores matters to buyers. Around 250 licensees were still looking for a site, capital, or both. The medical program had 19 approved registered organizations and 31 open medical dispensaries on the same date.

How does a sale work in New York?

Every sale is an ownership change approved in advance. Cannabis Law section 67 says a license becomes void on a change in ownership, a substantial corporate change, or a change of location made without prior written Board approval. There is no assignable license. The buyer’s owners, lenders with control rights, and certain service providers are vetted as true parties of interest through OCM’s TPI hub. A contractor paid more than the greater of 10% of gross revenue, 50% of net profit, or $250,000 a year is treated as a true party of interest, which catches many management and licensing deals. The general process is covered in change of ownership approval explained.

OCM does not publish a fixed review time. Deals are usually signed with closing conditioned on approval, as described in regulatory-approval contingencies.

Ownership limits and residency

Cannabis Law section 72 limits any person to three adult-use retail dispensary licenses. It also bars a retail licensee from holding an interest in a cultivator, processor, distributor or cooperative. That two-tier wall shapes the buyer pool: growers cannot buy stores, and store groups stop at three. There is no residency requirement for standard licenses, and the Second Circuit’s 2025 Variscite decision applied the dormant Commerce Clause to New York’s licensing preferences. See ownership caps and residency rules by state.

Social equity transfer limits

Under Cannabis Law section 87, a social and economic equity license cannot be transferred or sold for three years from issue, except to another qualified equity applicant with prior written Board approval. A non-equity buyer must also repay any outstanding Board loan. OCM reports that 55% of adult-use licenses went to equity applicants, so this rule touches most of the market. Detail is on selling a social equity license.

Local control

Cities, towns and villages had until 31 December 2021 to opt out of retail dispensaries and consumption sites, and may opt back in at any time. The Rockefeller Institute tracker counts 758 of 1,521 municipalities opted out of dispensaries. Opted-in municipalities may set time, place and manner rules within the limits of 9 NYCRR 119.2: for example, they cannot cut retail hours below 70 a week or set a youth-facility buffer above 500 feet. State rules add spacing of 1,000 feet between dispensaries in municipalities above 20,000 people and 2,000 feet in smaller ones, unless the Board grants a public convenience and advantage waiver. The school and house-of-worship measurement was reset by statute on 11 February 2026.

Taxes, 280E and track-and-trace

Retail sales carry a 13% tax, 9% state and 4% local. Distributors pay a further 9% on sales to retailers, which replaced the per-milligram THC tax on 1 June 2024. New York lets adult-use businesses deduct expenses that federal 280E disallows, for tax years from 1 January 2023, under Tax Law section 612 and the parallel corporate provisions. Federal 280E still applies to adult-use income. The state moved from BioTrack to Metrc, with all licensees credentialed by 17 December 2025, so a multi-year diligence review spans two systems.

Market conditions

Sales are growing and per-store sales are falling. OCM reports combined retail sales of about $1.6 billion for January to November 2025, against $1.0 billion in 2024 and $317 million in 2023. Open stores rose from 34 at the end of 2023 to 519 by November 2025. Annualized sales per store fell from $9.6 million in early 2023 to about $3.8 million in the third quarter of 2025. The average retail price per unit dropped about 15% from early 2024 to roughly $32, still above the national median.

Pricing of businesses has followed. In August 2026 Grown Rogue agreed to buy PharmaCann’s four New York dispensaries and a cultivation facility for about $4.5 million, with $3 million payable on change-of-control approval. The seller was under pressure, so treat it as a floor, not a benchmark.

What this means for sellers

Check the issue date on the license first. If it is an equity license under three years old, only another equity applicant can buy it. Map every true party of interest before marketing, because an undisclosed revenue-share agreement will surface in OCM review. A store with a protected site, where spacing rules keep competitors out, is worth more than its trailing sales suggest, and the file should prove it.

What this means for buyers

Count your existing interests against the three-store cap and the two-tier wall before signing a letter of intent. Underwrite on current per-store sales for the region, not on 2023 figures. Expect a no-licence-required position on the broker side: New York is reported as not requiring a licence to broker a business sale without real estate, as set out in business broker licensing by state. Local detail is on the New York City, Buffalo and Albany pages. This page is educational and is not legal or tax advice.